{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T07:33:52Z","timestamp":1766820832903},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2002,1,7]],"date-time":"2002-01-07T00:00:00Z","timestamp":1010361600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/1471-2369-3-1","type":"journal-article","created":{"date-parts":[[2002,10,11]],"date-time":"2002-10-11T18:42:27Z","timestamp":1034361747000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Activation of the Fas\/Fas ligand pathway in hypertensive renal disease in Dahl\/Rapp rats"],"prefix":"10.1186","volume":"3","author":[{"given":"Paul W","family":"Sanders","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-Xuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2002,1,7]]},"reference":[{"key":"4_CR1","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1161\/01.HYP.25.3.305","volume":"25","author":"VL Burt","year":"1995","unstructured":"Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, Horan MJ, Labarthe D: Prevalence of hypertension in the US adult population. Results from the third national health and nutrition examination survey, 1988\u20131991. Hypertension. 1995, 25: 305-313.","journal-title":"Hypertension"},{"key":"4_CR2","unstructured":"U.S Renal Data System.: USRDS 2001 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Disease, Bethesda, MD."},{"key":"4_CR3","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1161\/01.HYP.4.6.753","volume":"4","author":"JP Rapp","year":"1982","unstructured":"Rapp JP: Dahl salt-susceptible and salt-resistant rats. Hypertension. 1982, 4: 753-763.","journal-title":"Hypertension"},{"key":"4_CR4","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1161\/01.HYP.7.3.340","volume":"7","author":"JP Rapp","year":"1985","unstructured":"Rapp JP, Dene H: Development and characteristics of inbred strains of Dahl salt-sensitive and salt-resistant rats. Hypertension. 1985, 7: 340-349.","journal-title":"Hypertension"},{"key":"4_CR5","first-page":"174","volume":"68","author":"PY Chen","year":"1993","unstructured":"Chen PY, St. John PL, Kirk KA, Abrahamson DR, Sanders PW: Hypertensive nephrosclerosis in the Dahl\/Rapp rat: initial sites of injury and effect of dietary L-arginine administration. Lab Invest. 1993, 68: 174-184.","journal-title":"Lab Invest"},{"key":"4_CR6","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1161\/01.HYP.15.6.803","volume":"15","author":"CE Grim","year":"1990","unstructured":"Grim CE, Wilson TW, Nicholson GD, Hassell TA, Fraser HS, Grim CM: Blood pressure in blacks. Twin studies in Barbados. Hypertension. 1990, 15: 803-809.","journal-title":"Hypertension"},{"key":"4_CR7","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1046\/j.1523-1755.2000.00373.x","volume":"58","author":"W-Z Ying","year":"2000","unstructured":"Ying W-Z, Wang P-X, Sanders PW: Induction of apoptosis during development of hypertensive nephrosclerosis. Kidney Int. 2000, 58: 2007-2017. 10.1046\/j.1523-1755.2000.00373.x.","journal-title":"Kidney Int"},{"key":"4_CR8","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/0092-8674(91)90614-5","volume":"66","author":"N Itoh","year":"1991","unstructured":"Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S-I, Sameshima M, Hase A, Seto Y, Nagata S: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell. 1991, 66: 233-243.","journal-title":"Cell"},{"key":"4_CR9","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/0092-8674(93)90326-L","volume":"75","author":"T Suda","year":"1993","unstructured":"Suda T, Takahashi T, Golstein P, Nagata S: Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell. 1993, 75: 1169-1178.","journal-title":"Cell"},{"key":"4_CR10","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1084\/jem.186.12.2045","volume":"186","author":"T Suda","year":"1997","unstructured":"Suda T, Hashimoto H, Tanaka M, Ochi T, Nagata S: Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing. J Exp Med. 1997, 186: 2045-2050. 10.1084\/jem.186.12.2045.","journal-title":"J Exp Med"},{"key":"4_CR11","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1084\/jem.187.8.1205","volume":"187","author":"P Schneider","year":"1998","unstructured":"Schneider P, Holler N, Bodmer J-L, Hahne M, Frei K, Fontana A, Tschopp J: Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J Exp Med. 1998, 187: 1205-1213. 10.1084\/jem.187.8.1205.","journal-title":"J Exp Med"},{"key":"4_CR12","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/0092-8674(95)90071-3","volume":"81","author":"AM Chinnaiyan","year":"1995","unstructured":"Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM: FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell. 1995, 81: 505-512.","journal-title":"Cell"},{"key":"4_CR13","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S0092-8674(00)81266-0","volume":"85","author":"M Muzio","year":"1996","unstructured":"Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME, Dixit VM: FLICE, a novel FADD-homologous ICE\/CED-3-like protease, is recruited to the CD95 (Fas\/APO-1) death-inducing signaling complex. Cell. 1996, 85: 817-827. 10.1016\/S0092-8674(00)81266-0.","journal-title":"Cell"},{"key":"4_CR14","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1126\/science.281.5381.1305","volume":"281","author":"A Ashkenazi","year":"1998","unstructured":"Ashkenazi A, Dixit VM: Death receptors: signaling and modulation. Science (Wash DC). 1998, 281: 1305-1308. 10.1126\/science.281.5381.1305.","journal-title":"Science (Wash DC)"},{"key":"4_CR15","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S0092-8674(00)80430-4","volume":"91","author":"GS Salveson","year":"1998","unstructured":"Salveson GS, Dixit VM: Caspases: Intracellular signaling by proteolysis. Cell. 1998, 91: 443-446. 10.1016\/S0092-8674(00)80430-4.","journal-title":"Cell"},{"key":"4_CR16","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/S0092-8674(00)81589-5","volume":"94","author":"X Luo","year":"1998","unstructured":"Luo X, Budihardjo I, Zou H, Slaughter C, Wang X: Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell. 1998, 94: 481-490.","journal-title":"Cell"},{"key":"4_CR17","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S0092-8674(00)81590-1","volume":"94","author":"H Li","year":"1998","unstructured":"Li H, Zhu H, Xu C-j, Yuan J: Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell. 1998, 94: 491-501.","journal-title":"Cell"},{"key":"4_CR18","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1093\/emboj\/17.6.1675","volume":"17","author":"C Scaffidi","year":"1998","unstructured":"Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin K-M, Krammer PH, Peter ME: Two CD95 (APO-1\/Fas) signaling pathways. EMBO J. 1998, 17: 1675-1687. 10.1093\/emboj\/17.6.1675.","journal-title":"EMBO J"},{"key":"4_CR19","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1038\/ki.1997.239","volume":"51","author":"S Gonzalez-Cuadrado","year":"1997","unstructured":"Gonzalez-Cuadrado S, Lorz C, del Moral RG, O'Valle F, Alonso C, Ramiro F, Ortiz-Gonzalez A, Egido J, Ortiz A: Agonistic anti-Fas antibodies induce glomerular cell apoptosis in mice in vivo. Kidney Int. 1997, 51: 1739-1746.","journal-title":"Kidney Int"},{"key":"4_CR20","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1038\/ki.1996.155","volume":"49","author":"S Gonz\u00e1lez-Cuadrado","year":"1996","unstructured":"Gonz\u00e1lez-Cuadrado S, L\u00f3pez-Armada M-J, G\u00f3mez-Guerrero C, Subir\u00e1 D, Garcia-Sahuquillo A, Ortiz-Gonzalez A, Neilson EG, Egido J, Ortiz A: Anti-Fas antibodies induce cytolysis and apoptosis in cultured human mesangial cells. Kidney Int. 1996, 49: 1064-1070.","journal-title":"Kidney Int"},{"key":"4_CR21","first-page":"813","volume":"78","author":"JR Schelling","year":"1998","unstructured":"Schelling JR, Nkemere N, Kopp JB, Cleveland RP: Fas-dependent fratricidal apoptosis is a mechanism of tubular epithelial cell deletion in chronic renal failure. Lab Invest. 1998, 78: 813-824.","journal-title":"Lab Invest"},{"key":"4_CR22","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1046\/j.1523-1755.1999.00684.x","volume":"56","author":"JR Schelling","year":"1999","unstructured":"Schelling JR, Cleveland RP: Involvement of Fas-dependent apoptosis in renal tubular epithelial cell deletion in chronic renal failure. Kidney Int. 1999, 56: 1313-1316. 10.1046\/j.1523-1755.1999.00684.x.","journal-title":"Kidney Int"},{"key":"4_CR23","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1681\/ASN.V1171266","volume":"11","author":"C Lorz","year":"2000","unstructured":"Lorz C, Ortiz A, Justo P, Gonz\u00e1lez-Cuadrado S, Duque N, G\u00f3mez-Guerrero C, Egido J: Proapoptotic Fas ligand is expressed by normal kidney tubular epithelium and injured glomeruli. J Am Soc Nephrol. 2000, 11: 1266-1277.","journal-title":"J Am Soc Nephrol"},{"key":"4_CR24","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1038\/ki.1995.487","volume":"48","author":"T Takemura","year":"1995","unstructured":"Takemura T, Murakami K, Miyazato H, Yagi K, Yoshioka K: Expression of Fas antigen and Bcl-2 in human glomerulonephritis. Kidney Int. 1995, 48: 1886-1892.","journal-title":"Kidney Int"},{"key":"4_CR25","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1093\/ndt\/14.8.1831","volume":"14","author":"A Ortiz","year":"1999","unstructured":"Ortiz A, Lorz C, Egido J: The Fas ligand\/Fas system in renal injury. Nephrol Dial Transplant. 1999, 14: 1831-1834. 10.1093\/ndt\/14.8.1831.","journal-title":"Nephrol Dial Transplant"},{"key":"4_CR26","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1046\/j.1523-1755.2001.059002662.x","volume":"59","author":"W-Z Ying","year":"2001","unstructured":"Ying W-Z, Sanders PW: Cytochrome c mediates apoptosis in hypertensive nephrosclerosis in Dahl\/Rapp rats. Kidney Int. 2001, 59: 662-668. 10.1046\/j.1523-1755.2001.059002662.x.","journal-title":"Kidney Int"},{"key":"4_CR27","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1172\/JCI115467","volume":"88","author":"PY Chen","year":"1991","unstructured":"Chen PY, Sanders PW: L-arginine abrogates salt-sensitive hypertension in Dahl\/Rapp rats. J Clin Invest. 1991, 88: 1559-1567.","journal-title":"J Clin Invest"},{"issue":"4 Pt 2","key":"4_CR28","first-page":"H1293","volume":"277","author":"W-Z Ying","year":"1999","unstructured":"Ying W-Z, Sanders PW: Dietary salt increases endothelial nitric oxide synthase and TGF-\u03b2;1 in rat aortic endothelium. Am J Physiol. 1999, 277 (4 Pt 2): H1293-H1298.","journal-title":"Am J Physiol"},{"key":"4_CR29","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1046\/j.1523-1755.1998.00117.x","volume":"54","author":"W-Z Ying","year":"1998","unstructured":"Ying W-Z, Sanders PW: Expression of Tamm-Horsfall glycoprotein is regulated by dietary salt in rats. Kidney Int. 1998, 54: 1150-1156. 10.1046\/j.1523-1755.1998.00117.x.","journal-title":"Kidney Int"},{"key":"4_CR30","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1172\/JCI5628","volume":"104","author":"K Kuwano","year":"1999","unstructured":"Kuwano K, Hagimoto N, Kawasaki M, Yatomi T, Nakamura N, Nagata S, Suda T, Kunitake R, Maeyama T, Miyazaki H, Hara N: Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis. J Clin Invest. 1999, 104: 13-19.","journal-title":"J Clin Invest"},{"key":"4_CR31","doi-asserted-by":"crossref","first-page":"L298","DOI":"10.1152\/ajplung.2001.280.2.L298","volume":"280","author":"KL Serrao","year":"2001","unstructured":"Serrao KL, Fortenberry JD, Owens ML, Harris FL, Brown LAS: Neutrophils induce apoptosis of lung epithelial cells via release of soluble Fas ligand. Am J Physiol Lung Cell Mol Physiol. 2001, 280: L298-L305.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"4_CR32","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S0002-9440(10)64570-1","volume":"157","author":"M Kawasaki","year":"2000","unstructured":"Kawasaki M, Kuwano K, Hagimoto N, Matsuba T, Kunitake R, Tanaka T, Maeyama T, Hara N: Protection from lethal apoptosis in lipopolysaccharide-induced acute lung injury in mice by a caspase inhibitor. Am J Pathol. 2000, 157: 597-603.","journal-title":"Am J Pathol"},{"key":"4_CR33","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/ki.1996.14","volume":"49","author":"H Sugiyama","year":"1996","unstructured":"Sugiyama H, Kashihara N, Makino H, Yamasaki Y, Ota Z: Apoptosis in glomerular sclerosis. Kidney Int. 1996, 49: 103-111.","journal-title":"Kidney Int"},{"key":"4_CR34","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1111\/j.1523-1755.1998.00835.x","volume":"53","author":"SE Thomas","year":"1998","unstructured":"Thomas SE, Andoh TF, Pichler RH, Shankland SJ, Couser WG, Bennett WM, Johnson RJ: Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis. Kidney Int. 1998, 53: 897-908. 10.1046\/j.1523-1755.1998.00835.x.","journal-title":"Kidney Int"},{"key":"4_CR35","first-page":"S-14","volume":"49","author":"J Savill","year":"1996","unstructured":"Savill J, Mooney A, Hughes J: Apoptosis and renal scarring. Kidney Int. 1996, 49: S-14-S-17.","journal-title":"Kidney Int"},{"key":"4_CR36","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1681\/ASN.V94620","volume":"9","author":"S Nogae","year":"1998","unstructured":"Nogae S, Miyazaki M, Kobayashi N, Saito T, Abe K, Saito H, Nakane PK, Nakanishi Y, Koji T: Induction of apoptosis in ischemia-reperfusion model of mouse kidney: Possible involvement of Fas. J Am Soc Nephrol. 1998, 9: 620-631.","journal-title":"J Am Soc Nephrol"},{"key":"4_CR37","first-page":"1089","volume":"79","author":"S Khan","year":"1999","unstructured":"Khan S, Cleveland RP, Koch CJ, Schelling JR: Hypoxia induces renal tubular epithelial cell apoptosis in chronic renal disease. Lab Invest. 1999, 79: 1089-1099.","journal-title":"Lab Invest"},{"key":"4_CR38","doi-asserted-by":"publisher","first-page":"10453","DOI":"10.1074\/jbc.275.14.10453","volume":"275","author":"A-O Hueber","year":"2000","unstructured":"Hueber A-O, Z\u00f6rnig M, Bernard A-M, Chautan M, Evan G: A dominant negative Fas-associated death domain protein mutant inhibits proliferation and leads to impaired calcium mobilization in both T-cells and fibroblasts. J Biol Chem. 2000, 275: 10453-10462. 10.1074\/jbc.275.14.10453.","journal-title":"J Biol Chem"},{"key":"4_CR39","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1038\/3965","volume":"4","author":"J Desbarats","year":"1998","unstructured":"Desbarats J, Duke RC, Newell MK: Newly discovered role for Fas ligand in the cell-cycle arrest of CD4+ cells. Nature Med. 1998, 4: 1377-1382. 10.1038\/3965.","journal-title":"Nature Med"},{"issue":"6 Pt 2","key":"4_CR40","first-page":"F837","volume":"276","author":"LR Feldenberg","year":"1999","unstructured":"Feldenberg LR, Thevananther S, del Rio M, de Leon M, Devarajan P: Partial ATP depletion induces Fas- and caspase-mediated apoptosis in MDCK cells. Am J Physiol. 1999, 276 (6 Pt 2): F837-F846.","journal-title":"Am J Physiol"},{"key":"4_CR41","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/40901","volume":"388","author":"QL Deveraux","year":"1997","unstructured":"Deveraux QL, Takahashi R, Salvesen GS, Reed JC: X-linked IAP is a direct inhibitor of cell-death proteases. Nature (Lond). 1997, 388: 300-304. 10.1038\/40901.","journal-title":"Nature (Lond)"},{"key":"4_CR42","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1161\/01.RES.84.6.668","volume":"84","author":"W Erl","year":"1999","unstructured":"Erl W, Hansson GK, de Martin R, Draude G, Weber KSC, Weber C: Nuclear factor-\u03baB regulates induction of apoptosis and inhibitor of apoptosis protein-1 expression in vascular smooth muscle cells. Circ Res. 1999, 84: 668-677.","journal-title":"Circ Res"},{"key":"4_CR43","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1126\/science.281.5383.1680","volume":"281","author":"C-Y Wang","year":"1998","unstructured":"Wang C-Y, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AS: NF-\u03baB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science (Wash DC). 1998, 281: 1680-1683. 10.1126\/science.281.5383.1680.","journal-title":"Science (Wash DC)"},{"key":"4_CR44","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1126\/science.282.5387.290","volume":"282","author":"M Bennett","year":"1998","unstructured":"Bennett M, Macdonald K, Chan S-W, Luzio JP, Simari R, Weissberg P: Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis. Science (Wash). 1998, 282: 290-293. 10.1126\/science.282.5387.290.","journal-title":"Science (Wash)"},{"key":"4_CR45","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1161\/01.RES.86.10.1038","volume":"86","author":"S-W Chan","year":"2000","unstructured":"Chan S-W, Hegyi L, Scott S, Cary NRB, Weissberg PL, Bennett MR: Sensitivity to Fas-mediated apoptosis is determined below receptor level in human vascular smooth muscle cells. Circ Res. 2000, 86: 1038-1046.","journal-title":"Circ Res"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-3-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2369-3-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-3-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-3-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T15:32:32Z","timestamp":1726241552000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/1471-2369-3-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1,7]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2002,12]]}},"alternative-id":["4"],"URL":"https:\/\/doi.org\/10.1186\/1471-2369-3-1","relation":{},"ISSN":["1471-2369"],"issn-type":[{"type":"electronic","value":"1471-2369"}],"subject":[],"published":{"date-parts":[[2002,1,7]]},"assertion":[{"value":"1 October 2001","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2002","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2002","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"1"}}